Loss of FHIT expression in cervical carcinoma cell lines and primary tumors

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4692-4698

  Greenspan, David L ^a   Connolly, Denise C ^a   Wu, Rong ^a   Lei, Rachel Y ^a   Vogelstein, Joshua T C ^a   Kim, Young Tak ^b   Mok, Jung Eun ^b   Muñoz, Nubia ^c   Bosch, F Xavier ^d   Shah, Keerti ^e   Cho, Kathleen R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0030729465     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cervical Cancer. NIH Consensus Statement, 14: 1-38, Apr. 1-3, 1996.
2. Dyson, N., Howley, P., Münger, K., and Harlow, E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
3. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papilloma-virus types 16 and 18 E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
4. Slebos, R. J., Lee, M. H., Plunkett, B. S., Kessis, T. D., Williams, B. O., Jacks, T., Hedrick, L., Kastan, M. B., and Cho, K. R. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 91: 5320-5324, 1994.
5. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., and Cho, K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 90: 3988-3992, 1993.
6. Demers, G. W., Foster, S. A., Halbert, C. L., and Galloway, D. A. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7 Proc. Natl. Acad. Sci. USA, 91: 4382-4386, 1994.
7. Hickman, E. S., Picksley, S. M., and Vousden, K. H. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene, 9: 2177-2181, 1994.
8. Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T., and Terada, M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res., 49: 3598-3601, 1989.
9. Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, N., Tsuda, H., Hirohashi, S., Vissing, H., Shimizu, M., Oshimura, M., and Yokota, J. Deletion mapping of chromosome-3p in human uterine cervical cancer. Oncogene, 8: 1825-1832, 1993.
10. Karlsen, F., Rabbitts, P. H., Sundresan, V., and Hagmar, B. PCR-RFLP studies on chromosome 3p in formaldehyde-fixed, paraffin-embedded cervical cancer tissues. Int. J. Cancer, 58: 787-792, 1994.
11. Mitra, A. B., Murty, V. V. V. S., Li, R. G., Pratap, M., Luthra, U. K., and Chaganti, R. S. K. Allelotype analysis of cervical carcinoma. Cancer Res., 54: 4481-4487, 1994.
12. Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B., and Klinger, H. P. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res., 56: 197-205, 1996.
13. Rader, J. S., Kamarasova, T., Huettner, P. C., Li, L., Li, Y., and Gerhard, D. S. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene, 13: 2737-2741, 1997.
14. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3P14.2 fragile site acid renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
15. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F., and Minna, J. D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNa splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
16. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., Degregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3P14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
17. Yanagisawa, K., Kondo, M., Osada, H., Uchida, K., Takagi, K., Masuda, A., and Takahashi, T. Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. Cancer Res., 56: 5579-5582, 1996.
18. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
19. Geurts, J. M. W., Schoenmakers, F. P. M., Roijfer, E., Stenman, G., and Van de Ven, W. J. M. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res., 57: 13-17, 1997.
20. Shridhar, R., Shridhar, V., Wang, X., Paradee, W., Dugan, M., Sarkar, F., Wilke, C., Glover, T. W., Vaitkevicius, V. K., and Smith, D. I. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res., 56: 4347-4350, 1996.
21. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
22. Sozzi, G., Alder, H., Tornielli, S., Corletto, V., Baffa, R., Veronese, M. L., Negrini, M., Pilotti, S., Pierotti, M. A., Huebner, K., and Croce, C. M. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res., 56: 2472-2474, 1996.
23. Gemma, A., Hagiwara, K., Ke, Y., Burke, L. M., Khan, M. A., Nagashima, M., Bennett, W. P., and Harris, C. C. FHIT mutations in human primary gastric cancer. Cancer Res., 57: 1435-1437, 1997.
24. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Genet., 5: 187-195, 1996.
25. Scheffner, M., Münger, K., Byrne, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
26. Woodworth, C. D., Waggoner, S., Barnes, W., Stoler, M. H., and DiPaolo, J. A. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res., 50: 3709-3715, 1990.
27. Muñoz, N., Bosch, F. X., de Sanjose, S., Tafur, L., Izarzugaza, I., Gili, M., Viladiu, P., Navarro, C., Martos, C., Ascunce, N., Gonzalez, L. C., Kaldor, J. M., Guerrero, E., Lorincz, A., Santamaria, M., Deruiz, P. A., Aristizabal, N., and Shah, K. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer, 52: 743-749, 1992.
28. Bosch, F. X., Muñoz, N., de Sanjose, S., Izarzugaza, I., Gili, M., Viladiu, P., Tormo, M. J., Moreo, P., Ascunce, N., Gonzalez, L. C., Tafur, L., Kaldor, J. M., Guerrero, E., Aristizabal, N., Santamaria, M., Deruiz, P. A., and Shah, K. Risk factors for cervical cancer in Colombia and Spain. Int. J. Cancer, 52: 750-758, 1992.
29. Thiagalingam, S., Lisitsyn, N. A., Hamaguchi, M., Wigler, M. H., Willson, J. K. V., Markowitz, S. D., Leach, F. S., Kinzler, K. W., and Vogelstein, B. Evaluation of the FHIT gene in colorectal cancers. Cancer Res., 56: 2936-2939, 1996.
30. Druck, T., Hadaczek, P., Fu, T., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
31. Hendricks, D. T., Taylor, R., Reed, M., and Birrer, M. J. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res., 57: 2112-2115, 1997.
32. Baker, V. V., Hatch, K. D., and Shingleton, H. M. Amplification of the c-myc proto-oncogene in cervical carcinoma. J. Surg. Oncol., 39: 225-228, 1988.
33. Mitra, A. B., Murty, V. V., Pratap, M., Sodhani, P., and Chaganti, R. S. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. Cancer Res., 54: 637-639, 1994.
34. Heselmeyer, K., Schrock, E., Dumanoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., and Ried, T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA, 93: 479-484, 1996.
35. Wistuba, I. I., Montellano, F. D., Milchgrub, S., Virmani, A. K., Behrens, C., Chen, H., Ahmadian, M., Nowak, J. A., Muller, C., Minna, J. D., and Gazdar, A. F. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical cancer. Cancer Res., 57: 3154-3158, 1997.
36. Jones, M. H., and Nakamura, Y. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7: 1631-1634, 1992.
37. Zimonjic, D., Druck, T., Ohta, M., Kastury, K., Croce, C. M., Popescu, N., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
38. Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Pastorino, U., Huebner, K., Bevilaqua, M., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
39. Zou, T. T., Lei, J., Shi, Y. Q., Yin, J., Wang, S., Souza, R. F., Kong, D., Shimada, Y., Smolinski, K. N., Greenwald, B. D., Abraham, J. M., Harpaz, N., and Meltzer, S. J. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Oncogene, 15: 101-105, 1997.